Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v18-FR Version v13-EN
Language French English
Date Updated 2023-08-01 2023-07-18
Drug Identification Number 02339439 02339439
Brand name MYLAN-GALANTAMINE ER MYLAN-GALANTAMINE ER
Common or Proper name GALANTAMINE GALANTAMINE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients GALANTAMINE GALANTAMINE
Strength(s) 8MG 8MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 BT, 100 BT 30 BT, 100 BT
ATC code N06DA N06DA
ATC description ANTI-DEMENTIA DRUGS ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2023-06-07 2023-06-07
Actual start date 2023-05-29 2023-05-29
Estimated end date 2023-07-28 2023-08-01
Actual end date 2023-07-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments